|
|
|
|
|
 |
|
|
 |
|
|
|
|
Pharmacotherapeutics for Nurse Practitioner Prescribers, 2nd Edition
By
Anita Lee Wynne, RN, PhD, FNP-C, Professor, University of Portland, OR.
Teri Moser Woo, RN, MS, CPNP, Adjunct Instructor, University of Portland, OR.
Ali J. Olyaei, PharmD, BCPS, Associate Professor of Medicine, Division of Nephrology and Hypertension, Clinical Pharmacotherapist, Oregon Health Sciences University.
ISBN-13: 978-0-8036-1361-4
ISBN-10: 0-8036-1361-X
1,329 pp.
94 ill.
Hard cover.
©2007
Available now.
$124.00
|
|
|
|
|
|
Instructor’s Guide Online at DavisPlus (http://davisplus.fadavis.com).
Image bank • Case studies
|
Here’s the essential resource for the in-depth information
that Advanced Practice Nurses need to safely and effectively prescribe medication.
Focusing on applying pharmacologic scientific knowledge to clinical practice,
it explains diagnostic and treatment reasoning and rational drug selection,
while providing useful clinical pearls from experienced practitioners. The use
of a Rational Drug Selection process enables practitioners to understand how to
prescribe the right drug...for the right patient...at the right time!
The 2nd Edition has been comprehensively revised and updated
throughout to reflect the latest scientific and clinical knowledge. It’s the
only text that meets all AACN/NONPF criteria.
|
|
|
|
|
|
- The latest scientific and clinical knowledge.
- Discusses the application of advanced pharmacotherapeuticsto the real world of clinical practice.
- Significantly increased coverage of pathophysiology as itrelates the use of specific drugs.
- Three brand-new chapters: Pharmacogenomics,Pharmacoeconomics, and Pain Management.
- New content on drug therapy at the end of life.
- A completely revised chapter on herbal and complementarystrategies, written by an expert in the field.
- Uses easy-to-understand illustrations of drug physiologyand how drugs work in the body.
- Features tables that detail commonly used drugs,pharmacokinetics, drug/food interactions, dosage schedules, and available dosage forms.
- Provides tips on how to evaluate new drugs from theliterature provided by drug representatives.
- Highlights highlight potentially useful drugs currently inclinical trials in "On the Horizon" boxes.
- More "Clinical Pearls," and case studies.
|
|
|
|
|
I. The Foundation
1. Role of the Nurse Practitioner Prescriber
2. Review of Basic Pharmacology
3. Adverse drug reactions
4. Pharmacogenomics
5. Pharmacoeconomics
6. Rational Drug Selection
7. Legal and ethical issues in prescribing
8. Fostering adherence and positive outcomes
9. Cultural influences on Pharmacotherapeutics
10. Nutrition and Drug Therapy
11. Herbal and other complementary strategies
12. Information technology and pharmacology
13. Over-the-counter medications
II. Pharmacotherapeutics with Single Drugs
14. Drugs Affecting the Autonomic Nervous System
15. Drugs Affecting the Central Nervous System
16. Drugs Affecting the Cardiovascular and Renal systems
17. Drugs Affecting the Respiratory System
18. Drugs Affecting the Hematopoetic System
19. Drugs Affecting the Immune System
20. Drugs Affecting the Gastrointestinal System
21. Drugs Affecting the Endrocrine System
22. Drugs Affecting the Reproductive System
23. Drugs Affecting the Integumentary System
24. Drugs Used to Treat Inflammatatory Processes
25. Drugs Used in Infectious Diseases
26. Drugs Used to Treat Eye and Ear Disorders
III. Pharmacotherapeutics with Multiple Drugs
27. Anemia
28. Chronic Stable Angina and Low-risk Unstable Angina
29. Anxiety and Depression
30. Asthma and COPD
31. Contraception
32. Dermatologic conditions
33. Diabetes
34. Gastroesophageal reflux and peptic ulcer
35. Headaches
36. Heart Failure
37. HIV/AIDS
38. Hormone Replacement Therapy
39. Hyperlipidemia
40. Hypertension
41. Hyperthyroidism and Hypothyroidism
42. Pain Management: Acute and Chronic Pain
43. Pneumonia
44. Smoking Cessation
45. Sexually Transmitted Infections and Vaginitis
46. Tuberculosis
47. Upper Respiratory Infections/ Otitis media and Otitis externa
48. Urinary Tract Infections
IV. Drug Therapy for Special Populations
49. Women as Patients
50. Pediatric Patients
51. Geriatric Patients
52. Chronically ill and Long Term Care
53. Drug Therapy at the End of Life
|
|
|
| |
|
|
|
